ClinConnect ClinConnect Logo
Search / Trial NCT06376812

No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women

Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Apr 16, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Physical Activity Women's Health Minority Health Behavior Change Hypertension Prevention

ClinConnect Summary

The "No Time to Pause" clinical trial is looking at how physical activity can help improve the health of midlife Hispanic women who have elevated blood pressure and are experiencing symptoms of menopause. This study aims to encourage women aged 45-50 who are not currently active to engage in moderate exercise, with the goal of better managing their blood pressure and overall health.

To be eligible, participants must be women who identify as Hispanic, speak and read English, and have elevated blood pressure measurements. They should not be involved in any regular physical activity, should be generally healthy, and have access to a smart device for tracking their activity. The study is not yet recruiting participants, but once it starts, women who qualify will have the opportunity to participate in a program designed to help them become more active, which may lead to better health outcomes.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Female
  • 2. Hispanic by self-report
  • 3. Able to speak and read English
  • 4. Sedentary
  • 5. Age 45-50
  • 6. Diagnosed with elevated blood pressure or objectively measured systolic blood pressure 120-139 mmHg and/or diastolic blood pressure 80-89 mmHg averaged from ≥ 2 measures on ≥ 2 outpatient visits
  • 7. Symptoms consistent with the menopause transition (persistent difference of ≥7 days in the length of consecutive cycles; persistence is defined as recurrence within 10 cycles of the first variable length cycle)
  • 8. Apparently healthy
  • 9. Self-reported ability to engage in moderate intensity physical activity
  • 10. Access to a smart device that is compatible with a Fitbit application
  • Exclusion Criteria:
  • 1. Self-reported physical activity of ≥150 minutes per week
  • 2. Answered yes to any question on the Physical Activity Readiness (PAR-Q+) questionnaire
  • 3. Post-menopausal (12-months without a menstrual cycle)
  • 4. Diagnosed hypertension
  • 5. Cardiovascular, respiratory, neurological, renal, endocrine, gastrointestinal and/or psychiatric diseases, or any cancers
  • 6. Previous hysterectomy, oophorectomy, and/or uterine ablation
  • 7. Medication to treat hypertension, elevated glucose, cholesterol, depression, anxiety, and insomnia
  • 8. Hormonal medication via any route or implants
  • 9. Tamoxifen
  • 10. Pregnant, planning to become pregnant, or breastfeeding
  • 11. Planning to move out of the Galveston/Houston area in the next 18 months
  • 12. Current participation in another physical activity study or program

About The University Of Texas Medical Branch, Galveston

The University of Texas Medical Branch (UTMB) in Galveston is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. As a prominent sponsor of clinical trials, UTMB leverages its extensive resources, multidisciplinary expertise, and commitment to excellence to facilitate groundbreaking studies that address critical health challenges. With a focus on translating scientific discoveries into effective therapies, UTMB fosters collaboration among researchers, clinicians, and participants to enhance patient outcomes and contribute to the overall advancement of medical knowledge.

Locations

Patients applied

0 patients applied

Trial Officials

Elizabeth Lorenzo, PhD, RN

Principal Investigator

University of Texas

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported